ICCC

MKT CAP:$87M

ImmuCell Corporation

Market Cap

$87M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$9.61+$3.69 (+62.33%)

Jun 5, 2026

52W High $10.6352W Low $4.56

Company Details

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours...

CEO

—

IPO Date

Apr 30, 1987

Website

immucell.com

Key Metrics TTM

Revenue

$30M

+9.6% YoY

Net Income

-$545.4K

EPS (Diluted)

Free Cash Flow

$3M

Revenue / Share

$3.31

Gross Margin

42.6%

Operating Margin

8.4%

Net Margin

-1.8%

FCF Margin

11.3%

P/S

2.9x

P/E

Earnings Reports

Q2 2026

Aug 13, 2026

PENDING

Q1 2026

May 14, 2026

$10M+28.4%

FY 2025

Mar 30, 2026

$28M+4.3%

Q4 2025

Mar 30, 2026

$8M-1.6%

Q3 2025

Nov 13, 2025

$6M-8.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee